Loading clinical trials...
Loading clinical trials...
Early Detection of Lung Cancer: Metabolic Biomarkers for High Risk Screening (MEDLUNG)
Conditions
Interventions
immunohistochemistry staining method
laboratory biomarker analysis
+3 more
Locations
2
United Kingdom
Prince Philip Hospital
Llanelli, Wales, United Kingdom
South West Wales Cancer Institute
Swansea, Wales, United Kingdom
Start Date
April 1, 2008
Primary Completion Date
April 1, 2011
Last Updated
August 26, 2013
NCT07336732
NCT07190248
NCT07486219
NCT06305754
NCT05198830
NCT05692635
Lead Sponsor
South West Wales Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions